Aneuploidy screening: Newer noninvasive test gains traction

Author and Disclosure Information



Finally, while cfDNA is routinely recommended for women with pregnancies considered at high risk for aneuploidy, many insurance companies do not cover the cost of cfDNA for women with low-risk pregnancies, and the test may cost up to $1,700.12 The overall cost-effectiveness of cfDNA for aneuploidy screening in low-risk women is unknown.

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.


Copyright © 2016. The Family Physicians Inquiries Network. All rights reserved.

Online-Only Materials

PDF icon JFP06501049_methodology216.03 KB

Next Article:

Can aspirin prevent breast cancer?

Related Articles